Supplier News
Subscribe to Supplier News

The Lead

Global Dyslipidemia Treatment Market Value Will Approach $38B by 2023

May 19, 2015 8:44 am | by Valentina Gburcik, Ph.D., Director of Cardiovascular & Metabolic Disorders, GlobalData | Articles | Comments

The global treatment market for dyslipidemia will more than double in value from $15.4 billion in 2013 to an estimated $37.9 billion by 2023. Read more...

Endo to Buy Par Pharmaceutical for Generic Drug Advantage

May 19, 2015 8:33 am | by Ryan Bushey, Associate Editor | Articles | Comments

Endo spent 8.5 billion on the company for a few key reasons. Read more...

Fibromyalgia Treatment Market Value Will Crawl to $1.9B by 2023

May 15, 2015 8:47 am | by Maura Musciacco, MSc, GlobalData's Director or Neurology and Opthalmology | Articles | Comments

The company’s latest report states that while this growth will be primarily driven by the...

Novartis' Lung Cancer Drug Gets European Approval

May 8, 2015 8:46 am | News | Comments

The approval of Zykadia in the European Union provides patients with advanced ALK+ NSCLC...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Mylan Launches Sovaldi Tablets in India

May 6, 2015 8:21 am | News | Comments

Mylan has launched Gilead Sciences' Sovaldi tablets in India. Read more...

Prostate Cancer Treatment Market Value Will Triple to $8.2B by 2023

May 5, 2015 8:33 am | by Raksha Mudbhary, Ph.D., GlobalData Senior Oncology Analyst | Articles | Comments

The global treatment market value for prostate cancer, excluding hormonal and bone therapies, will expand more than threefold from $2.6 billion in 2013 to an estimated $8.2 billion by 2023. Read more...

Gilead's Hepatitis C Drugs Made About $4.45B in Sales in Q1

May 4, 2015 3:06 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This news greatly surpassed analyst expectations.


Mylan Declines Teva's $40B Takeover Attempt

April 27, 2015 12:08 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The executive chairman for Mylan wrote a letter to Teva citing a number of issues as to why this merger would be a bad idea. Read more...

Roche Sales Up 3 Percent Amid Demand for Breast Cancer Drugs

April 23, 2015 9:15 am | by The Associated Press | News | Comments

Breast cancer drugs such as Herceptin as well as new uses for multi-cancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by 3 percent during the first quarter. Read more...

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 9:11 am | by The Associated Press | News | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies. Read more...

Actelion Advances Clinical Development of its Specialty Immunology Pipeline Compounds

April 17, 2015 8:12 am | News | Comments

Actelion announced that it is accelerating its clinical development efforts in the field of immunological disorders. Read more...

Daiichi Sankyo, Terumo Apply for Manufacturing and Sales Approval of Flu Vaccine in Japan

April 13, 2015 8:22 am | News | Comments

The Vaccine is a pre-filled syringe type, intradermal influenza HA vaccine co-developed by four companies under a February 23, 2012, agreement. Read more...


New Therapeutic Option Available for Select Treatment Resistant Lung Cancer Patients

April 8, 2015 8:22 am | News | Comments

NSCLC can be characterized based on a patient's genetic abnormalities that are causing the cancer growth and researchers have identified over 12 of these genetic abnormalities. Read more...

Mylan Launches First Generic Version of Generess Fe

April 8, 2015 8:21 am | News | Comments

Mylan has 269 ANDAs pending FDA approval representing $104.1 billion in annual brand sales. Read more...

New R&D Alliance Forms to Find First-Ever Biomarker for Pancreatic Cancer

April 7, 2015 11:49 am | by Ryan Bushey, Associate Editor | Articles | Comments

This program will utilize a precision medicine approach to potentially find a cure for this disease. Read more...

BMS, uniQure to Collaborate on Developing Gene Therapies for Cardiovascular Diseases

April 6, 2015 4:42 pm | News | Comments

Bristol-Myers Squibb and uniQure N.V. announced an agreement that provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases. Read more...

GSK to Establish Global Vaccines R&D Center in the U.S.

April 6, 2015 8:17 am | News | Comments

GSK announced it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre for vaccines research and development in Rockville, Maryland. Read more...


Novo to Launch Novoeight in the U.S. for People With Hemophilia A

March 29, 2015 3:38 pm | News | Comments

The US Food and Drug Administration (FDA) approved Novoeight for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis. Read more...

Nanoparticle Therapy Promotes Wound Healing

March 27, 2015 2:00 pm | by Yeshiva University | News | Comments

An experimental therapy can cut in half the time it takes to heal wounds compared to no treatment at all. Read more...

Novo Nordisk Resubmits NDA for Tresiba, Ryzodeg in U.S.

March 26, 2015 4:38 pm | News | Comments

The resubmission is expected to take place within the next month. Read more...

FDA to Scrutinize Unproven Alternative Remedies

March 26, 2015 12:42 pm | by Matthew Perrone, AP Health Writer | News | Comments

Federal officials plan to review the safety and evidence behind alternative remedies like Zicam and Cold-Eeze, products that are protected by federal law, but not accepted by mainstream medicine. Read more...

Sepsis-Specific Treatment Market Will Expand from 2016, Reach $354M by 2021

March 25, 2015 12:28 pm | by Marc C. Hansel, Ph.D., GlobalData Infectious Diseases Analyst | Articles | Comments

GlobalData's latest report states that this growth will be driven by the increased uptake of novel therapies. Read more...

Cipher Pharmaceuticals Acquires Canadian Rights to Novel Psoriasis, Rheumatoid Arthritis Treatment

March 24, 2015 8:54 am | News | Comments

Approximately 500,000 in Canada people receive treatment for psoriasis. Read more...

Biogen: Positive Phase 1 Results for Alzheimer's Drug

March 23, 2015 8:26 am | News | Comments

Treatment with the drug produced a dose and time dependent reduction of amyloid plaque in the brain. Read more...

FDA Panel Backs GSK Inhaler for Adults, Not Adolescents

March 20, 2015 9:47 am | by Matthew Perrone, AP Health Writer | News | Comments

Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents. Read more...

AstraZeneca, Daiichi Sankyo to Jointly Commercialize Movantik in U.S.

March 19, 2015 4:28 pm | News | Comments

Movantik is a first-in-class once-daily oral peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation. Read more...

Novartis Gains EU Approval for Rare Blood Cancer Drug

March 19, 2015 9:06 am | News | Comments

This medication is the first targeted treatment approved by the European Commission for these patients. Read more...

Roche Launches Next-Generation Duplex Test for Parovirus B19, Hepatitis A

March 18, 2015 8:56 am | News | Comments

This test is only available in markets accepting the CE mark. Read more...

Pfizer Reports Top-Line Results from Phase 4 Study Evaluating Fibromyalgia Capsules

March 16, 2015 8:33 am | News | Comments

The primary endpoint of the study was not achieved as there was not a statistically significant difference between pregabalin and placebo in mean pain score. Read more...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.